COVID-19: Moderna applies for authorisation of vaccine in U.S., EU

United States firm, Moderna, said it would submit its Coronavirus (COVID-19) vaccine for emergency authorisation use by the U.S. Food and Drug Administration and conditional approval from the European Medicines Agency (EMA) yesterday.


The company said in a statement that it planned to submit the necessary applications for approval of the use of its vaccine in the U.S. and European Union.


Moderna said it had already initiated so-called rolling review processes with the EMA, as well as with regulatory authorities in Canada, Switzerland, Britain, Israel, and Singapore, aimed at speeding up authorisation.


Moderna also released results of its follow-up phase 3 COVE study, involving 30,000 participants, which show its vaccine is 94.1-per cent effective in preventing infection with COVID-19. Earlier interim results said it was 94.5-per cent effective against the virus.


The company says the vaccine trials have so far raised no serious safety concerns.


Abuja Man reveals (FREE) secret Fruits that Increased his Manh00d size and Lasting Power in 5days…


%d bloggers like this:
Fake Richard Mille Replica Watches, The ceramic upper and lower cases are imported from Taiwan and are processed by ATPT ceramics to form Y-TZP ceramics. After high-tech anti-fingerprint technology, they present a delicate and soft sub-black material. This color quality has remained unchanged for a hundred years. The color and luster are more detailed to achieve the ceramic tone visual pattern electroplating upper and lower shells that are infinitely close to the original products, with anti-reflective coating sapphire glass! The tape uses a soft and delicate Malaysian imported top rubber strap, and the movement is equipped with an imported Seiko NH movement. The buckle of this version is made according to the original size and thinness, making it feel more comfortable and intimate, the highest version on the market Richard Mille Replica